ANTIPODES PARTNERS Ltd boosted its stake in shares of Semrush Holdings, Inc. (NASDAQ:SEMR – Free Report) by 902.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 23,681 shares of the company’s stock after buying an additional 21,319 shares during the period. ANTIPODES PARTNERS Ltd’s holdings in Semrush were worth $281,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Verition Fund Management LLC lifted its holdings in Semrush by 278.9% during the 3rd quarter. Verition Fund Management LLC now owns 134,531 shares of the company’s stock valued at $2,113,000 after buying an additional 99,021 shares in the last quarter. Barclays PLC boosted its holdings in shares of Semrush by 115.2% in the 3rd quarter. Barclays PLC now owns 102,407 shares of the company’s stock valued at $1,609,000 after acquiring an additional 54,830 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of Semrush in the 4th quarter valued at $6,869,000. Y Intercept Hong Kong Ltd lifted its stake in shares of Semrush by 166.7% in the 4th quarter. Y Intercept Hong Kong Ltd now owns 103,221 shares of the company’s stock valued at $1,226,000 after purchasing an additional 64,514 shares during the period. Finally, SG Americas Securities LLC lifted its stake in shares of Semrush by 329.4% in the 4th quarter. SG Americas Securities LLC now owns 56,089 shares of the company’s stock valued at $666,000 after purchasing an additional 43,027 shares during the period. 32.86% of the stock is owned by hedge funds and other institutional investors.
Semrush Stock Performance
NASDAQ SEMR opened at $10.01 on Thursday. The firm has a market cap of $1.47 billion, a price-to-earnings ratio of 125.08 and a beta of 1.77. The firm has a 50 day simple moving average of $14.72 and a 200-day simple moving average of $14.00. Semrush Holdings, Inc. has a one year low of $9.45 and a one year high of $18.74.
Analysts Set New Price Targets
Get Our Latest Research Report on SEMR
Insiders Place Their Bets
In other news, Director Dmitry Melnikov sold 42,226 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $13.50, for a total transaction of $570,051.00. Following the completion of the transaction, the director now owns 9,099,091 shares of the company’s stock, valued at $122,837,728.50. This represents a 0.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CMO Andrew Warden sold 8,462 shares of the business’s stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $11.71, for a total value of $99,090.02. Following the sale, the chief marketing officer now owns 276,656 shares of the company’s stock, valued at $3,239,641.76. The trade was a 2.97 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 481,253 shares of company stock worth $6,192,121. Corporate insiders own 57.83% of the company’s stock.
Semrush Profile
Semrush Holdings, Inc develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally. The company enables companies to identify and reach the right audience for their content through the right channels. Its platform enables the company's customers to understand trends and act upon insights to enhance the online visibility, and drive traffic to their websites and social media pages, as well as online listings, distribute targeted content to their customers, and measure the digital marketing campaigns.
See Also
- Five stocks we like better than Semrush
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- How to Most Effectively Use the MarketBeat Earnings Screener
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- 3 Healthcare Dividend Stocks to Buy
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding SEMR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semrush Holdings, Inc. (NASDAQ:SEMR – Free Report).
Receive News & Ratings for Semrush Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semrush and related companies with MarketBeat.com's FREE daily email newsletter.